Berkley Heights, NJ, United States of America

Edward Orton



Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Lansdale, PA (US) (2003)
  • Berkley Heights, NJ (US) (2010)

Company Filing History:


Years Active: 2003-2010

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Edward Orton: Innovator in Pharmaceutical Chemistry

Introduction

Edward Orton, based in Berkeley Heights, NJ, is a prominent inventor known for his contributions to pharmaceutical chemistry. With two patents to his name, he has made significant strides in developing innovative solutions for various medical conditions. His work primarily focuses on compounds that target specific biological pathways to alleviate symptoms associated with numerous disorders.

Latest Patents

Edward Orton's latest patent is directed toward the Dihydrogen phosphate salt of a prostaglandin D2 receptor antagonist. This invention comprises a pharmaceutical composition that includes a pharmaceutically effective amount of a specific compound designed to treat various PGD2-mediated disorders, including allergic diseases, bronchial asthma, and chronic inflammatory conditions. The compound is characterized by its ability to provide therapeutic relief by addressing underlying mechanisms associated with these disorders.

Another significant patent of Orton addresses the method and reagents for the quantification of solid-phase reactions using fluorine NMR. This advancement utilizes fluorine NMR spectroscopy to monitor and quantify solid-phase reactions, offering a new way to enhance the efficiency and accuracy of chemical assays in pharmaceutical research.

Career Highlights

Edward Orton is associated with Aventis Pharmaceuticals Inc., where he has leveraged his expertise to drive innovative research and development initiatives. His work has been instrumental in creating pharmaceutical products that improve patient outcomes and contribute to advancements in the medical field.

Collaborations

Throughout his career, Orton has collaborated with notable professionals such as Beverly C Langevin and Daniel Sherer. These collaborations have fostered an environment of innovation, allowing for the sharing of ideas and expertise necessary for advancing their collective work in pharmaceuticals.

Conclusion

In conclusion, Edward Orton's contributions to pharmaceutical chemistry and his innovative patents position him as a valuable inventor in the medical field. His dedication to developing effective therapies reflects his commitment to addressing significant health challenges, enhancing the quality of life for patients. With his ongoing efforts, the potential for future breakthroughs in medicine remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…